FORM OF AMENDED AND RESTATED SHAREHOLDERS’ RIGHTS AGREEMENT BY AND AMONG CFIP CLYD LLC, CFIP CLYD (UK) LIMITED AND CELYAD ONCOLOGY SA Dated as of , 2023Shareholders’ Rights Agreement • August 24th, 2023 • Fortress Investment Group LLC • Investment advice • New York
THIS AMENDED AND RESTATED SHAREHOLDERS’ RIGHTS AGREEMENT (this “Agreement”) is made as of , 2023, by and among CFIP CLYD LLC, a Delaware limited liability company (“CFIP”), CFIP CLYD (UK) Limited, a U.K. private limited company (“UKF”), and Celyad Oncology SA, a limited liability company incorporated and existing in the form of a naamloze vennootschap / société anonyme under Belgian law, having its registered office at Rue Edouard Belin 2, 1435 Mont-Saint-Guibert (Belgium) and registered with the Crossroads Bank for Enterprises under number 0891.118.115 (RLE Brabant Wallon) (the “Company”).
SUBSCRIPTION AGREEMENT Between CFIP CLYD (UK) LIMITED AND CELYAD ONCOLOGY SA Dated as of August 24, 2023Subscription Agreement • August 24th, 2023 • Fortress Investment Group LLC • Investment advice • New York
THIS SUBSCRIPTION AGREEMENT (this “Agreement”), dated as of August 24, 2023 (the “Effective Date”), is entered into between CFIP CLYD (UK) Limited (“UKF”), a U.K. private limited company (the “Investor”), and Celyad Oncology SA, a limited liability company incorporated and existing in the form of a naamloze vennootschap / société anonyme under Belgian law, having its registered office at Rue Edouard Belin 2, 1435 Mont-Saint-Guibert (Belgium) and registered with the Crossroads Bank for Enterprises under number 0891.118.115 (RLE Brabant Wallon) (the “Company”).
